Anti‑CD20 and ‑PD‑1 antibody effects on proliferation, apoptosis and cell cycle of endometrial cancer cells
Oncology Letters · 17.06.2026 · 32 (2) · 1-9
DOI: 10.3892/ol.2026.15712 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Letters, online erschienen am 17.06.2026. Verfasst von Jinqiu Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530200, P.R. China. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gynecology, Guangxi Medical University Cancer Hospital, Nanning, Guangxi 530200, P.R. China.
- Guangxi Key Laboratory of Early Prevention and Treatment of Regional High-Incidence Tumors, Nanning, Guangxi 530021, P.R. China.
Zitieren
APA
Su, J., Du, J., Yu, Y., Feng, M., Huang, Q., Liu, B., & Wang, H. (2026). Anti‑CD20 and ‑PD‑1 antibody effects on proliferation, apoptosis and cell cycle of endometrial cancer cells. Oncology Letters, 32(2), 1-9. https://doi.org/10.3892/ol.2026.15712
Vancouver
Su J, Du J, Yu Y, Feng M, Huang Q, Liu B, et al. Anti‑CD20 and ‑PD‑1 antibody effects on proliferation, apoptosis and cell cycle of endometrial cancer cells. Oncology Letters. 2026;32(2):1-9. doi:10.3892/ol.2026.15712
BibTeX
@article{Su2026,
author = {Su, Jinqiu and Du, Jiayuan and Yu, Yaojie and Feng, Mei and Huang, Qiuyue and Liu, Bing and Wang, He},
title = {Anti‑CD20 and ‑PD‑1 antibody effects on proliferation, apoptosis and cell cycle of endometrial cancer cells},
journal = {Oncology Letters},
year = {2026},
volume = {32},
number = {2},
pages = {1--9},
doi = {10.3892/ol.2026.15712}
}
EUVIMED